Discontinuation report CLONAZEPAM

Last updated on 2017-11-06 History
Report ID 28145
Drug Identification Number 02442027
Brand name CLONAZEPAM
Common or Proper name CLONAZEPAM
Company Name SIVEM PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) CLONAZEPAM
Strength(s) 0.25MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N03AE
ATC description ANTIEPILEPTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-11-01
Remaining supply date 2017-11-05
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2017-11-06 French Compare
v1 2017-11-06 English Compare

Showing 1 to 2 of 2